Home/ Supplements/ Vitamin K/ Circulation VA

Circulation VA

product on market Capsule Redd Remedies Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Horse chestnut and ginger are supported by moderate evidence for improving circulation and reducing leg swelling. Vitamin K2 plays a role in calcium regulation, though overall evidence coverage for this specific blend is limited. The ingredient profile maintains a high safety score.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Circulation VA
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Vegetarian Capsule(s)
Serving Size
30
Servings
Botanical with Nutrients
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

180 mcg (225% DV)
1.5× RDA — within safe limits 275 studies (A:9, B:175)
Market median: 250.0mg (337 products) 127 studies (A:1, B:41)
Market median: 285.0mg (90 products) 1 studies — no high-quality reviews
Antioxidant Blend
280 mg

Other Ingredients

Vegetarian Capsule Tapioca Flour Bamboo leaf extract
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Use: 2 capsules daily with meals. Best taken in divided doses.

Warnings & Precautions

WARNING: If pregnant, nursing, or taking prescription drugs, discuss all products used with a healthcare practitioner.

Keep out of reach of children.

Vitamin K2 may counteract the effects of anticoagulation therapy, and therefore is not recommended for patients on blood-thinning medications.

Formulation Notes

Non-GMO Soy Free

Gluten Free

CONTAINS NO: soy, sugar, yeast, wheat, gluten, dairy products, artificial flavoring or coloring, preservatives or animal ingredients.

Additional Information

{capsule} Actual Size

Quality & Purity Guaranteed

VEINS & ARTERIES

~Supports healthy veins and arteries ~Supports circulation ~Promotes arterial flexibility

Vegetarian

Store in a cool, dry place.

Quality & Purity Guaranteed Laboratory Tested

Metadata

Product Details

UPC / SKU8 55735 00130 9
DSLD Entry Date2016-01-25
Product TypeBotanical with Nutrients
FormCapsule
DSLD ID56117
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.